CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · IEX Real-Time Price · USD
3.91
0.00 (0.00%)
At close: Aug 17, 2022 4:00 PM
3.89
-0.02 (-0.51%)
After-hours: Aug 17, 2022 7:52 PM EDT

Ratios and Metrics (Annual)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Current20212020201920182017201620152014
Market Capitalization
3312333951354684044140144
Market Cap Growth
--40.98%193.65%-71.21%15.92%894.86%2.37%-72.55%-
Enterprise Value
25098250-55289312327114
PE Ratio
--2.59-7.75-1.31-6.45-14.64-1.52-2.55-4.52
PS Ratio
-----40.35---
PB Ratio
4.011.762.770.722.754.7510.301.4110.42
EV/Sales Ratio
-----38.74---
Debt / Equity Ratio
1.000.380.010.01-0.072.240.330.33
Debt / EBITDA Ratio
-0.88-0.59-0.02-0.02--0.23-0.35-0.64-0.14
Debt / FCF Ratio
-1.07-0.73-0.03-0.02--0.31-0.38-0.40-0.21
Current Ratio
13.2710.4115.3811.5112.606.351.996.881.82
Asset Turnover
-00000.16000
Return on Equity (ROE)
-101.60%-79.20%-31.90%-46.10%-37.70%-60.30%-207.50%-63.70%-213.40%
Return on Assets (ROA)
-59.20%-62.20%-29.70%-42.60%-34.50%-43.60%-95.80%-40.00%-91.60%
Return on Capital (ROIC)
-67.20%-103.40%-48.20%-60.00%-49.60%-66.60%-152.90%-52.90%-360.60%
Earnings Yield
-31.40%-38.60%-12.90%-76.30%-15.50%-6.80%-65.80%-39.20%-22.10%
FCF Yield
-23.40%-29.80%-11.30%-72.90%-11.90%-4.90%-57.70%-58.90%-14.70%
Buyback Yield / Dilution
-27.28%-3.14%-2.77%-15.90%-65.71%-48.86%-23.95%-57.00%-323.42%
Total Shareholder Return
-27.28%-3.14%-2.77%-15.90%-65.71%-48.86%-23.95%-57.00%-323.42%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).